TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21139088

Group type: EXPERIMENTAL
Intervention: ASMA (Asthma Self‐Management for Adolescents)
Number of subjects: 345

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 345
Study: 18286692

Group type: EXPERIMENTAL
Intervention: New reconstructive method using fast-absorbable suture material (irradiated polyglactin 910) and a temporary stent tube
Number of subjects: 63

Group type: COMPARATOR
Intervention: Conventional duct-to-mucosa anastomosis
Number of subjects: 63
Study: 16773409

Group type: EXPERIMENTAL
Intervention: Fosinopril and prednisone for 12 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Prednisone alone for 12 weeks
Number of subjects: 45
Study: 14690574

Group type: EXPERIMENTAL
Intervention: Xeloda and radiotherapy (Group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Operation alone (Group A)
Number of subjects: 60
Study: 10722990

Group type: EXPERIMENTAL
Intervention: Access to walking trails
Number of subjects: 1269

Group type: EXPERIMENTAL
Intervention: Use of walking trails
Number of subjects: 1269

Group type: EXPERIMENTAL
Intervention: Demographics of trail users
Number of subjects: 1269

Group type: EXPERIMENTAL
Intervention: Education level and walking increase
Number of subjects: 1269
Study: 8704804

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) 1 mg/kg injected transvaginally or 1.5 mg/kg IM if necessary (group 1)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Laparoscopic salpingotomy (group 2)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Laparoscopic salpingotomy
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) and Laparoscopic salpingotomy
Number of subjects: 89
Study: 1495823

Group type: EXPERIMENTAL
Intervention: Nonsteroidal anti-inflammatory drugs (NSAIDs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NSAIDs
Number of subjects: 0
Study: 6666698

Group type: EXPERIMENTAL
Intervention: Daily calorie referencing with no further calorie goals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate calorie referencing with subgoals for meals and snacks
Number of subjects: 0
Study: 31148436

Group type: EXPERIMENTAL
Intervention: 2017 AHA/ACC guideline criteria (BP ≥ 130/80 mmHg)
Number of subjects: 3420
Study: 30767504

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen at 6 L/min for 6 to 12 hours delivered by open face mask
Number of subjects: 6629

Group type: COMPARATOR
Intervention: Ambient air
Number of subjects: 6629
Study: 27035501

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 26248454

Group type: EXPERIMENTAL
Intervention: Plasma eardrum perforation homochronous with palatoplasty
Number of subjects: 56

Group type: COMPARATOR
Intervention: Palatoplasty alone (Control)
Number of subjects: 56
Study: 22361603

Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 51

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 51
Study: 20622335

Group type: EXPERIMENTAL
Intervention: Compound Polygonum multiflorum extract
Number of subjects: 209

Group type: COMPARATOR
Intervention: Polygonum multiflorum extract (Chinese herb control)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Naofukang (western medicine control)
Number of subjects: 209
Study: 18630111

Group type: EXPERIMENTAL
Intervention: Scaling-Root Planing (SRP)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: SRP + Nd: YAG laser irradiation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nd: YAG laser irradiation alone
Number of subjects: 60
Study: 15789103

Group type: EXPERIMENTAL
Intervention: Galloy restorations
Number of subjects: 14

Group type: COMPARATOR
Intervention: Dispersalloy restorations
Number of subjects: 14
Study: 12354084

Group type: EXPERIMENTAL
Intervention: Er:YAG laser radiation at 60 mJ
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Er:YAG laser radiation at 100 mJ
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Er:YAG laser radiation at 180 mJ
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Mechanical treatment using curettes
Number of subjects: 85

Group type: COMPARATOR
Intervention: Untreated control samples
Number of subjects: 85
Study: 10407818

Group type: EXPERIMENTAL
Intervention: Doxapram (0.5 mg/kg/h continuous infusion)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Theophylline (loading dose 5 mg/kg, 3 mg/kg bid)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Doxapram
Number of subjects: 34

Group type: COMPARATOR
Intervention: Theophylline
Number of subjects: 34
Study: 7592232

Group type: EXPERIMENTAL
Intervention: Experimental condition (self-efficacy enhancement)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 25
Study: 2075080

Group type: EXPERIMENTAL
Intervention: Cefuroxime
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Combination of both agents (Cefuroxime + Metronidazole)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control (no antibiotic prophylaxis)
Number of subjects: 68
Study: 7013057

Group type: EXPERIMENTAL
Intervention: Physical training (home-training and group-training led by a physiotherapist) for 4 to 8 years
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no physical training)
Number of subjects: 46
Study: 31145109

Group type: EXPERIMENTAL
Intervention: Bodyweight exercises (Cook hip lift)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bodyweight exercises
Number of subjects: 20
Study: 29284737

Group type: EXPERIMENTAL
Intervention: Individualized regular coaching on physical activity and exercise every month for 18 consecutive months
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Individualized regular coaching on physical activity and exercise
Number of subjects: 380

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 380
Study: 27826183

Group type: EXPERIMENTAL
Intervention: Lesinurad 400 mg
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Lesinurad 1,600 mg (supratherapeutic dose)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 24641639

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided periclavicular plexus blocks
Number of subjects: 6366

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 6366
Study: 22528707

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drugs (AADs) - metoprolol, propafenone, verapamil
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drugs (AADs) - responders
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation (RFCA)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drugs (AADs) - long-term follow-up
Number of subjects: 84
Study: 20233135

Group type: EXPERIMENTAL
Intervention: Deferred invasive treatment (balloon angioplasty or coronary bypass surgery)
Number of subjects: 751

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 751

Group type: EXPERIMENTAL
Intervention: Deferred invasive treatment
Number of subjects: 751
Study: 16929241

Group type: EXPERIMENTAL
Intervention: Soymilk intervention (one serving)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Baseline (no intervention)
Number of subjects: 43
Study: 16380891

Group type: EXPERIMENTAL
Intervention: Computer-assisted cup replacement using the orthopilot navigation system
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional instrumented cup replacement
Number of subjects: 100
Study: 11850523

Group type: EXPERIMENTAL
Intervention: Target velocity of 10-40 deg x s(‐1) with an ISI of 2.4 s
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Target velocity constant at 40 deg x s(‐1) with ISI varying from 0.48-3.74 s
Number of subjects: 0

Group type: COMPARATOR
Intervention: Predictive responses compared with responses to randomised presentation
Number of subjects: 0
Study: 9797801

Group type: EXPERIMENTAL
Intervention: Sampatrilat (50 mg, 100 mg, 200 mg)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Lisinopril (20 mg)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Sampatrilat
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study: 7706943

Group type: EXPERIMENTAL
Intervention: Lovastatin (20 mg/day)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 2624612

Group type: EXPERIMENTAL
Intervention: 10 mg nifedipine (generic preparation P)
Number of subjects: 12

Group type: COMPARATOR
Intervention: 10 mg nifedipine (reference preparation R)
Number of subjects: 12
Study: 188622

Group type: EXPERIMENTAL
Intervention: Toothpaste W (calcium phosphate, sodium laurylsulfate, sodium sulforicinoleate)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Toothpaste X
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Toothpaste Y
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Toothpaste Z
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo paste V
Number of subjects: 53
Study: 30647445

Group type: EXPERIMENTAL
Intervention: Loading dose guided by pharmacogenetics (LDG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Maintenance dose (MDG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 28670721

Group type: EXPERIMENTAL
Intervention: Very Elderly group (age >80 years)
Number of subjects: 580

Group type: COMPARATOR
Intervention: Elderly group (age 75-80 years)
Number of subjects: 580
Study: 26098993

Group type: EXPERIMENTAL
Intervention: Pegylated interferon
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Pegylated interferon/ribavirin
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Duration of HCV infection
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: IFNL4 genotype
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Baseline HCV RNA <400,000 IU/mL
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Age ≥40 years
Number of subjects: 516
Study: 23474089

Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 20

Group type: COMPARATOR
Intervention: Soybean oil
Number of subjects: 20
Study: 21685340

Group type: EXPERIMENTAL
Intervention: TF (WHO simplified criteria grades of follicular trachoma)
Number of subjects: 2111

Group type: EXPERIMENTAL
Intervention: TI (WHO simplified criteria grades of intense trachomatous inflammation)
Number of subjects: 2111

Group type: EXPERIMENTAL
Intervention: PCR (Polymerase Chain Reaction)
Number of subjects: 2111
Study: 19212856

Group type: EXPERIMENTAL
Intervention: Vitamin B12
Number of subjects: 100

Group type: COMPARATOR
Intervention: Nortriptyline
Number of subjects: 100
Study: 16452738

Group type: EXPERIMENTAL
Intervention: Perioperative infiltration mixture of local anesthetic and self-administered morphine
Number of subjects: 42

Group type: COMPARATOR
Intervention: Self-administered morphine only (Control)
Number of subjects: 42
Study: 15128706

Group type: EXPERIMENTAL
Intervention: Comprehensive community intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Problems identified and their assumed causes
Number of subjects: 0
Study: 11166665

Group type: EXPERIMENTAL
Intervention: Inactivated intra-nasal anti-influenza vaccine
Number of subjects: 274

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 274
Study: 10783117

Group type: EXPERIMENTAL
Intervention: Amprenavir
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Amprenavir, zidovudine, and lamivudine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study: 8938911

Group type: COMPARATOR
Intervention: Placebo washout period
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose antipsychotic treatment
Number of subjects: 0
Study: 1726005

Group type: EXPERIMENTAL
Intervention: Lacidipine
Number of subjects: 131

Group type: COMPARATOR
Intervention: Nifedipine SR
Number of subjects: 131

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Lacidipine 2 mg
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Lacidipine 4 mg
Number of subjects: 131
Study: 6217951

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (IB) followed by metaproterenol (Met)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Ipratropium bromide (IB) alone
Number of subjects: 10

Group type: COMPARATOR
Intervention: Metaproterenol (Met) alone
Number of subjects: 10

Group type: COMPARATOR
Intervention: Two consecutive inhalations of Met
Number of subjects: 10

Group type: COMPARATOR
Intervention: Met followed by IB
Number of subjects: 10
Study: 30668281

Group type: EXPERIMENTAL
Intervention: Sodium Bicarbonate 0.2 g/kg BM (SBC2)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Sodium Bicarbonate 0.3 g/kg BM (SBC3)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Sodium Bicarbonate (SBC2 and SBC3)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 14
Study: 29976736

Group type: EXPERIMENTAL
Intervention: Computed tomography scans (CT scans)
Number of subjects: 1093

Group type: EXPERIMENTAL
Intervention: Cumulative red bone marrow dose from CT scans
Number of subjects: 1093

Group type: COMPARATOR
Intervention: Control group (no CT scans)
Number of subjects: 1093
Study: 26689864

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with cisplatin (80 mg/m(2)) and paclitaxel (200 mg/m(2)) followed by concurrent chemoradiotherapy (66 Gy in 33 fractions, cisplatin 80 mg/m(2) days 1, 29 and 57, vinorelbine 15 mg/m(2) days 1, 8, 29, 36, 57 and 64)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy followed by two cycles of cisplatin and paclitaxel
Number of subjects: 127
Study: 24769888

Group type: EXPERIMENTAL
Intervention: Intracoronary injection of G-CSF-mobilized BMSCs
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (serum)
Number of subjects: 9
Study: 22318279

Group type: COMPARATOR
Intervention: Ciprofloxacin (250 mg orally twice daily for 3 days)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Cefpodoxime (100 mg orally twice daily for 3 days)
Number of subjects: 300
Study: 20667681

Group type: EXPERIMENTAL
Intervention: Contingency management (CM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 17440210

Group type: EXPERIMENTAL
Intervention: Volunteers for the prison study
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (psychological study without prison life context)
Number of subjects: 0
Study: 15699479

Group type: EXPERIMENTAL
Intervention: Nadroparin
Number of subjects: 302

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Nadroparin (subgroup with life expectancy of 6 months or more)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Placebo (subgroup with life expectancy of 6 months or more)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Nadroparin (subgroup with shorter life expectancy)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Placebo (subgroup with shorter life expectancy)
Number of subjects: 302